NovaBay Says Its Avenova Cuts Bacteria On Ocular Skin Surface By Over 90%
May 03, 2016 at 08:43 AM EDT
NovaBay Pharmaceuticals, Inc. (NYSE: NBY) revealed the presentation of clinical data demonstrating that its Avenova reduced the ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.